Ahammune

Pune, India · Founded 2016 · Privately Held (backing)

Developer of novel drugs designed to treat the early stages of Vitiligo. Ahammune is based in Pune, India and was founded in 2016. Its last known valuation is $24.4 million. It has raised $7.2 million.

Last price · $/share
—
Implied valuation
$24.4M
Total raised
$7.2M
Last round
—

Who backs Ahammune?

17 investors
InvestorType
Indian Angel NetworkAngel
Venture CenterOther
Survam PartnersFamily office
Legacy AssetsFamily office
Ajith Kamath—
Anand Deshpande—
Bipin Agarwal—
Capital 2B—
Colossa Ventures—
Ganesh Natarajan—
+ 7 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Ahammune investors

17 investors are on record for Ahammune, including Indian Angel Network, Venture Center, Survam Partners and Legacy Assets.

Free account
More of Ahammune with a free account
  • ·The complete investor list: 17 names
  • ·Watch Ahammune: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 17 firms already write checks for companies like Ahammune. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View